The wireless polysomnography market size is projected to be worth US$ 197.7 million in 2023. The market is likely to surpass US$ 329.8 million by 2033 at a CAGR of 5.2% during the forecast period. The phases and cycles of sleep are monitored using polysomnography equipment. Modern polysomnography (PSG) equipment may remotely communicate data to medical professionals for processing.
In the upcoming years, the availability of both portable and stationary devices is predicted to drive market growth. Devices that are small and portable are becoming more popular. For market participants, the creation of software with precise and thorough analytical capabilities is anticipated to provide profitable development potential.
Other Drivers Propelling the Demand for Wireless Polysomnography include:
Challenges for Companies /Manufacturers in the Wireless Polysomnography Market:
Opportunities in the Wireless Polysomnography Industry:
Latest Trends in the Wireless Polysomnography Market:
| Attributes | Details |
|---|---|
| Wireless Polysomnography Market Size (2023) | US$ 197.7 million |
| Wireless Polysomnography Market Projected Size (2033) | US$ 329.8 million |
| Value CAGR (2023 to 2033) | 5.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global wireless polysomnography market experienced a CAGR of 3.6%, reaching a market size of US$ 197.7 million in 2023.
From 2012 to 2022, the global wireless polysomnography industry witnessed steady growth due to the greater mobility and ease of use. Polysomnography was mostly performed in sleep labs using wired equipment. Wireless PSG systems were designed to provide a more convenient and comfortable option. Because of their greater mobility and ease of use, wireless PSG systems have grown in popularity. Adoption in sleep clinics and hospitals has increasing.
Wireless communication and sensor technology advancements have greatly expanded the possibilities of wireless PSG systems. As a result, data gathering, analysis, and patient comfort have all improved.
Future Forecast for Wireless Polysomnography Industry:
Looking ahead, the global wireless polysomnography industry is expected to rise at a CAGR of 5.2% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 329.8 million by 2033.
The wireless polysomnography industry is expected to continue its growth trajectory from 2023 to 2033, driven by increasing prevalence of sleep apnea. Sleep disorders including sleep apnea and insomnia are growing increasingly common as a result of causes such as lifestyle changes, stress, and ageing populations. This trend is projected to boost future demand for wireless PSG systems.
Home-based sleep monitoring is becoming more popular as a way to improve patient comfort and convenience while lowering healthcare expenses. Wireless PSG devices are ideal for this application because they allow patients to complete sleep studies in the comfort of their own homes.
| Country | The United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 105.7 million |
| CAGR % 2023 to End of Forecast (2033) | 4.7% |
The wireless polysomnography industry in the United States is expected to reach a market size of US$ 105.7 million by 2033, expanding at a CAGR of 4.7%. Wireless polysomnography is expected to see growth in the US market due to the increasing prevalence of sleep-related disorders. The America Sleep Association estimates that between 50 and 70 million individuals in the USA have sleep apnea in 2021. In the United States, sleep problems are fairly common, thus a proper diagnosis is also quite important. As a result, the country is adopting wireless polysomnography equipment for medical diagnostics.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 20.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.4% |
The wireless polysomnography industry in the United Kingdom is expected to reach a market value of US$ 20.1 million, expanding at a CAGR of 6.4% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing government initiatives and favorable policies. The government of the United Kingdom has taken, or is preparing to take, a number of actions to combat obstructive sleep apnea cycle. In section 3.10, the government lists sleep apnea as an adult impairment. Such patients receive additional advantages, from education to therapy, removing any financial strain. The above-mentioned regulations all increased the need for wireless polysomnography.
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 21.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.0% |
The wireless polysomnography industry in China is anticipated to reach a market size of US$ 21.1 million, moving at a CAGR of 6.0% during the forecast period. The wireless polysomnography industry in China is expected to grow prominently due to the increasing prevalence of sleep related disorders. Obstructive sleep apnea and other sleep disorders are quite prevalent in China. According to the paper A narrative review of obstructive sleep apnea in China: A sleeping giant in disease pathology, in Heart Mind 2022, 176 million Chinese citizens suffer from obstructive sleep apnea. This rising prevalence contributes to the market growth for wireless polysomnography in the country.
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 15.2 million |
| CAGR % 2023 to End of Forecast (2033) | 5.7% |
The wireless polysomnography industry in Japan is estimated to reach a market size of US$ 15.2 million by 2033, thriving at a CAGR of 5.7%. The market in Japan is predicted to grow because of the growing awareness and acceptance. There is an increasing need for efficient treatment alternatives, such as polysomnography in the country as more individuals are becoming aware of the health dangers linked to disorders that cause sleep disorder issues. The elderly population in Japan is another significant market driver. The chance of developing sleep apnea rises with age, increasing the need for polysomnography.
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 12.3 million |
| CAGR % 2023 to End of Forecast (2033) | 6.3% |
The wireless polysomnography industry in South Korea is expected to reach a market size of US$ 12.3 million, expanding at a CAGR of 6.3% during the forecast period. In South Korea, sleeplessness is more common than earlier. People who experience the symptoms of insomnia report a worsening of their quality of life in many areas and have a higher risk of developing other psychiatric illnesses. Thus, the rising incidence of insomnia is increasing people's knowledge of sleep problems, which is assisting the market's expansion.
Principal Consultant
The up-to 24 channel PSG systems is expected to dominate the wireless polysomnography industry with a CAGR of 4.4% from 2023 to 2033. Since there are more devices in the range of up to 24 channel PSG systems available than in the other product categories, this sector dominates the market for wireless polysomnography equipment.
The Ambulatory PSG segments are expected to dominate the wireless polysomnography industry with a CAGR of 5.6% from 2023 to 2033. This segment captures a significant market share in 2023.
Ambulatory PSG sleep tests are increasingly being used to diagnose sleep disorders. Ambulatory PSG allows to conduct of an overnight polysomnography assessment while the patient is still at home. These technologies provide sleep clinics with the flexibility of wireless and portable PSG systems by transporting sleep studies from the sleep clinic to the patient's home.
The Obstructive sleep apnea (OSA) segments is expected to dominate the wireless polysomnography industry with a CAGR of 4.7% from 2023 to 2033. As the occurrences of obstructive sleep apnea are increasing in comparison to the other sectors, this category is going to hold a considerable market share in 2023.
Polysomnography captures and classifies sleep phases, as well as the occurrence and duration of apneic and hypopneic episodes. It is useful for verifying OSA diagnosis and assessing OSA severity.
The sleep laboratories segment is expected to dominate the wireless polysomnography industry with a CAGR of 4.7% from 2023 to 2033. The increasing number of clinics sleep clinics or laboratories in the field of sleep medicine is a key factor due to which the sleep laboratories have been estimated to account for more than half of the share of the end user segment in the forecast period as well.
The wireless polysomnography sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
Key players focus on developing and introducing innovative products to address unmet needs in the market. They invest in research and development to improve existing formulations, delivery systems, and enhance the efficacy and safety of the products
Key players often form strategic partnerships and collaborations with other companies, research institutes, or healthcare organizations, these partnerships allow for knowledge sharing, joint research and development efforts, and access to complementary technologies or expertise.
Key players strive to expand their presence in different geographic regions to tap into new markets and reach a wider customer base. They may establish subsidiaries, distribution networks or strategic alliances in various countries to strengthen their market position.
Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Wireless Polysomnography Market:
The global wireless polysomnography industry is expected to hit a value of US$ 197.7 million by 2023.
The wireless polysomnography demand is set to expand by 5.2% during the assessment period.
The Up-to 24 Channel PSG Systems is projected to hold the dominant share of the market.
The market is predicted to exceed US$ 329.8 million by 2033.
The United States offers key opportunities for new entrants in the wireless polysomnography industry.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends and Supply Side Trends
1.3. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USPs
4.3. Technological Roadmap
4.4. Regulatory Landscape
4.5. PESTEL Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Increasing Prevalence of Sleep Disorders
5.2.3. Favourable Government Regulations
5.2.4. Rising Demand for Home Sleep Testing
5.2.5. Technological Advancement in Wireless Technology
5.2.6. Key Market Players Strategic Partnerships and Collaborations
5.2.7. Growing Awareness and Education Initiatives
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
6.1. Historical Volume (in Units) Analysis, 2012 to 2022
6.2. Current and Future Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Up-to 12 Channel PSG Systems
9.3.2. Up-to 24 Channel PSG Systems
9.3.3. Up-to 32 Channel PSG Systems
9.3.4. Above 32 Channel PSG Systems
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Application, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
10.3.1. Ambulatory Polysomnography
10.3.2. In-laboratory Polysomnography
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Therapeutic Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Therapeutic Indication, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Therapeutic Indication, 2023 to 2033
11.3.1. Obstructive Sleep Apnea
11.3.2. Narcolepsy
11.3.3. Chronic Insomnia
11.3.4. Others
11.4. Market Attractiveness Analysis By Therapeutic Indication
12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Sleep Laboratories
12.3.4. Home Care Settings
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By Therapeutic Indication
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By Therapeutic Indication
14.4.5. By End User
14.5. Country Level Analysis & Forecast
14.5.1. USA Market Analysis
14.5.1.1. .Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By Application
14.5.1.2.3. By Therapeutic Indication
14.5.1.2.4. By End User
14.5.2. Canada Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Product
14.5.2.2.2. By Application
14.5.2.2.3. By Therapeutic Indication
14.5.2.2.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By Therapeutic Indication
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By Therapeutic Indication
15.4.5. By End User
15.5. Country Level Analysis & Forecast
15.5.1. Brazil Market Analysis
15.5.1.1. .Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Application
15.5.1.2.3. By Therapeutic Indication
15.5.1.2.4. By End User
15.5.2. Mexico Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Application
15.5.2.2.3. By Therapeutic Indication
15.5.2.2.4. By End User
15.5.3. Argentina Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Product
15.5.3.2.2. By Application
15.5.3.2.3. By Therapeutic Indication
15.5.3.2.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. France
16.3.1.3. Italy
16.3.1.4. UK
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By Therapeutic Indication
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By Therapeutic Indication
16.4.5. By End User
16.5. Country Level Analysis & Forecast
16.5.1. Germany Market Analysis
16.5.1.1. .Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Application
16.5.1.2.3. By Therapeutic Indication
16.5.1.2.4. By End User
16.5.2. France Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Application
16.5.2.2.3. By Therapeutic Indication
16.5.2.2.4. By End User
16.5.3. Italy Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Application
16.5.3.2.3. By Therapeutic Indication
16.5.3.2.4. By End User
16.5.4. UK Market Analysis
16.5.4.1. .Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product
16.5.4.2.2. By Application
16.5.4.2.3. By Therapeutic Indication
16.5.4.2.4. By End User
16.5.5. Spain Market Analysis
16.5.5.1. .Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Product
16.5.5.2.2. By Application
16.5.5.2.3. By Therapeutic Indication
16.5.5.2.4. By End User
16.5.6. Russia Market Analysis
16.5.6.1. .Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Product
16.5.6.2.2. By Application
16.5.6.2.3. By Therapeutic Indication
16.5.6.2.4. By End User
16.5.7. BENELUX Market Analysis
16.5.7.1. .Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Product
16.5.7.2.2. By Application
16.5.7.2.3. By Therapeutic Indication
16.5.7.2.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Application
17.3.4. By Therapeutic Indication
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By Therapeutic Indication
17.4.5. By End User
17.5. Country Level Analysis & Forecast
17.5.1. India Market Analysis
17.5.1.1. .Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Application
17.5.1.2.3. By Therapeutic Indication
17.5.1.2.4. By End User
17.5.2. Thailand Market Analysis
17.5.2.1. .Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Application
17.5.2.2.3. By Therapeutic Indication
17.5.2.2.4. By End User
17.5.3. Indonesia Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Application
17.5.3.2.3. By Therapeutic Indication
17.5.3.2.4. By End User
17.5.4. Malaysia Market Analysis
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Product
17.5.4.2.2. By Application
17.5.4.2.3. By Therapeutic Indication
17.5.4.2.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Application
18.3.4. By Therapeutic Indication
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By Therapeutic Indication
18.4.5. By End User
18.5. Country Level Analysis & Forecast
18.5.1. China Market Analysis
18.5.1.1. .Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Application
18.5.1.2.3. By Therapeutic Indication
18.5.1.2.4. By End User
18.5.2. Japan Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Application
18.5.2.2.3. By Therapeutic Indication
18.5.2.2.4. By End User
18.5.3. South Korea Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Application
18.5.3.2.3. By Therapeutic Indication
18.5.3.2.4. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By Therapeutic Indication
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By Therapeutic Indication
19.4.5. By End User
19.5. Country Level Analysis & Forecast
19.5.1. Australia Market Analysis
19.5.1.1. .Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Application
19.5.1.2.3. By Therapeutic Indication
19.5.1.2.4. By End User
19.5.2. New Zealand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Application
19.5.2.2.3. By Therapeutic Indication
19.5.2.2.4. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By Therapeutic Indication
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application
20.4.4. By Therapeutic Indication
20.4.5. By End User
20.5. Country Level Analysis & Forecast
20.5.1. GCC Countries Market Analysis
20.5.1.1. .Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Application
20.5.1.2.3. By Therapeutic Indication
20.5.1.2.4. By End User
20.5.2. Türkiye Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Application
20.5.2.2.3. By Therapeutic Indication
20.5.2.2.4. By End User
20.5.3. Northern Africa Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Application
20.5.3.2.3. By Therapeutic Indication
20.5.3.2.4. By End User
20.5.4. South Africa Market Analysis
20.5.4.1. Introduction
20.5.4.2. Market Analysis and Forecast by Market Taxonomy
20.5.4.2.1. By Product
20.5.4.2.2. By Application
20.5.4.2.3. By Therapeutic Indication
20.5.4.2.4. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Branding and Promotional Strategies, By Key Players
22.3. Key Development Analysis
22.4. Competition Deep Dive
22.4.1. Nox Medical
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Key Financials
22.4.1.4. Sales Footprint
22.4.1.5. SWOT Analysis
22.4.1.6. Strategy Overview
22.4.1.6.1. Marketing Strategy
22.4.1.6.2. Product Strategy
22.4.1.6.3. Channel Strategy
22.4.2. Onera Technologies B.V.
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Key Financials
22.4.2.4. Sales Footprint
22.4.2.5. SWOT Analysis
22.4.2.6. Strategy Overview
22.4.2.6.1. Marketing Strategy
22.4.2.6.2. Product Strategy
22.4.2.6.3. Channel Strategy
22.4.3. SOMNOmedics GmbH
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Key Financials
22.4.3.4. Sales Footprint
22.4.3.5. SWOT Analysis
22.4.3.6. Strategy Overview
22.4.3.6.1. Marketing Strategy
22.4.3.6.2. Product Strategy
22.4.3.6.3. Channel Strategy
22.4.4. Recorders & Medicare Systems P Ltd.
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Key Financials
22.4.4.4. Sales Footprint
22.4.4.5. SWOT Analysis
22.4.4.6. Strategy Overview
22.4.4.6.1. Marketing Strategy
22.4.4.6.2. Product Strategy
22.4.4.6.3. Channel Strategy
22.4.5. VentMed Technology Medical Co. Ltd
22.4.5.1. Overview
22.4.5.2. Product Portfolio
22.4.5.3. Key Financials
22.4.5.4. Sales Footprint
22.4.5.5. SWOT Analysis
22.4.5.6. Strategy Overview
22.4.5.6.1. Marketing Strategy
22.4.5.6.2. Product Strategy
22.4.5.6.3. Channel Strategy
22.4.6. Koninklijke Philips N.V.
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Key Financials
22.4.6.4. Sales Footprint
22.4.6.5. SWOT Analysis
22.4.6.6. Strategy Overview
22.4.6.6.1. Marketing Strategy
22.4.6.6.2. Product Strategy
22.4.6.6.3. Channel Strategy
22.4.7. Allengers Medical Systems Limited
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Key Financials
22.4.7.4. Sales Footprint
22.4.7.5. SWOT Analysis
22.4.7.6. Strategy Overview
22.4.7.6.1. Marketing Strategy
22.4.7.6.2. Product Strategy
22.4.7.6.3. Channel Strategy
22.4.8. Natus Medical Incorporated
22.4.8.1. Overview
22.4.8.2. Product Portfolio
22.4.8.3. Key Financials
22.4.8.4. Sales Footprint
22.4.8.5. SWOT Analysis
22.4.8.6. Strategy Overview
22.4.8.6.1. Marketing Strategy
22.4.8.6.2. Product Strategy
22.4.8.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Wireless Polysomnography Market
